Who is sponsoring NCT02684045?

NCT02684045 is sponsored by Medtronic Spinal and Biologics.

What condition does NCT02684045 study?

NCT02684045 studies Subjects Received MAGNIFUSE in Posterolateral Lumbar Spine.

Is NCT02684045 still recruiting?

NCT02684045 is currently completed. Last updated 21 August 2017.

Last reviewed 2017-08-21 · How we verify

NCT02684045

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Retrospective Chart Review to Assess Outcomes in Subjects That Received MAGNIFUSE® in the Posterolateral Lumbar Spine

Completed Last updated 21 August 2017

What this trial tests

trial in Subjects Received MAGNIFUSE in Posterolateral Lumbar Spine in 76 participants. Completed in 15 August 2017.

Timeline

1 March 2017

Primary endpoint
15 August 2017

15 August 2017

Quick facts

Lead sponsor	Medtronic Spinal and Biologics
Status	Completed
Study type	OBSERVATIONAL
Enrollment	76
Start date	1 March 2017
Primary completion	15 August 2017
Estimated completion	15 August 2017
Sites	2 locations across United States

Conditions studied

Subjects Received MAGNIFUSE in Posterolateral Lumbar Spine — all drugs for Subjects Received MAGNIFUSE in Posterolateral Lumbar Spine →

Sponsor

Medtronic Spinal and Biologics — full company profile →

Who can join

Eligibility, any sex, with Subjects Received MAGNIFUSE in Posterolateral Lumbar Spine. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this chart review is to assess outcomes in subjects that received MAGNIFUSE in the posterolateral lumbar spine at 1 or 2 continuous levels from L1-S1.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Allografts and Spinal Fusion.
Cohen JD, Kanim LE, Tronits AJ, Bae HW. · · 2021 · cited 14× · PMID 34376497 · DOI 10.14444/8056

Verify or expand the search:

Other Medtronic Spinal and Biologics trials

Trials by the same sponsor.

NCT07414745 — MDT-0123 Japan Study · NA · not yet recruiting
NCT05299762 — A Post Market Surveillance on INFUSE Bone Graft · recruiting
NCT04929678 — Study of the Braive Growth Modulation System for Progressive Pediatric Scoliosis · NA · terminated
NCT03775694 — Diffusion MRI-1 Imaging Database · completed
NCT03797144 — Fenestrated Screw Study · NA · terminated

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02684045 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Medtronic Spinal and Biologics
Last refreshed: 21 August 2017

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02684045.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing